Results 101 to 110 of about 2,129,895 (283)
BACKGROUND AND OBJECTIVE: Professional assistants are among the learners whose ability in terms of professional ethics and commitment influences their future performance after graduation so that, as an excellent physician, they can combine patient care ...
N Nikbakhsh +10 more
doaj
AMA Code of Medical Ethics' Opinion on Physician Stewardship [PDF]
AMA Council on Ethical and Judicial Affairs
openalex +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Research hotspots and development trends of medical ethics and bioethics [PDF]
Introduction: The objective is to examine the conceptual structure of research related to medical ethics and bioethics in the Web of Science database and to identify the sub-domains and important dimensions of these concepts.
Saleh Rahimi +2 more
doaj
Can Osler Teach us About 21st-Century Medical Ethics? [PDF]
Mark Millard
openalex +1 more source
Thematic Analysis of Military Medical Ethics Publications From 2000 to 2020—A Bibliometric Approach [PDF]
Zachary Bailey +3 more
openalex +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source

